The investment-grade notes are due 2030 and 2045

Davis Polk advised the underwriters in connection with an SEC-registered offering of €1.5 billion aggregate principal amount of notes by Medtronic, Inc., consisting of €750 million aggregate principal amount of 2.950% senior notes due 2030 and €750 million aggregate principal amount of 4.200% senior notes due 2045. The notes are fully and unconditionally guaranteed by Medtronic plc and Medtronic Global Holdings S.C.A. Medtronic plc is the parent company of Medtronic Global Holdings S.C.A., and Medtronic Global Holdings S.C.A. is an indirect parent company of Medtronic, Inc.

Medtronic plc, headquartered in Galway, Ireland, is the leading global healthcare technology company. Medtronic was founded in 1949. It employs more than 95,000 people worldwide and serves healthcare systems, physicians, clinicians and patients in more than 150 countries worldwide.

The Davis Polk capital markets team included partner Deanna L. Kirkpatrick, counsel Jennifer (Ying) Lan and associate Yan Zhan. Partner Michael Mollerus and associate Hunter P. Shaw provided tax advice. The intellectual property team included partner David R. Bauer and associates Gabrielle Mazero and Hannah Coleman. Members of the Davis Polk team are based in the New York and Northern California offices.

Copy link to share post